-
1
-
-
53249123632
-
-
4th edn. International Agency for Research on Cancer (IARC): Lyon
-
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn. International Agency for Research on Cancer (IARC): Lyon, 2008.
-
(2008)
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
-
-
Swerdlow, S.H.1
Campo, E.2
Harris, N.L.3
Jaffe, E.S.4
Pileri, S.A.5
Stein, H.6
-
2
-
-
47549083663
-
The myelodysplastic/myeloproliferative neoplasms: Myeloproliferative diseases with dysplastic features
-
Orazi A, Germing U. The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features. Leukemia 2008; 22: 1308-1319.
-
(2008)
Leukemia
, vol.22
, pp. 1308-1319
-
-
Orazi, A.1
Germing, U.2
-
3
-
-
70349256226
-
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes
-
Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114: 937-951.
-
(2009)
Blood
, vol.114
, pp. 937-951
-
-
Vardiman, J.W.1
Thiele, J.2
Arber, D.A.3
Brunning, R.D.4
Borowitz, M.J.5
Porwit, A.6
-
4
-
-
33747610392
-
Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features
-
DOI 10.1038/sj.leu.2404316, PII 2404316
-
Wang SA, Hasserjian RP, Loew JM, Sechman EV, Jones D, Hao S et al. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features. Leukemia 2006; 20: 1641-1644. (Pubitemid 44264118)
-
(2006)
Leukemia
, vol.20
, Issue.9
, pp. 1641-1644
-
-
Wang, S.A.1
Hasserjian, R.P.2
Loew, J.M.3
Sechman, E.V.4
Jones, D.5
Hao, S.6
Liu, Q.7
Zhao, W.8
Mehdi, M.9
Galili, N.10
Woda, B.11
Raza, A.12
-
5
-
-
45149121653
-
Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease- unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis
-
DOI 10.1038/sj.leu.2405054, PII 2405054
-
Atallah E, Nussenzveig R, Yin CC, Bueso-Ramos C, Tam C, Manshouri T et al. Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis. Leukemia 2008; 22: 1295-1298. (Pubitemid 351833812)
-
(2008)
Leukemia
, vol.22
, Issue.6
, pp. 1295-1298
-
-
Atallah, E.1
Nussenzveig, R.2
Yin, C.C.3
Bueso-Ramos, C.4
Tam, C.5
Manshouri, T.6
Pierce, S.7
Kantarjian, H.8
Verstovsek, S.9
-
6
-
-
39749120756
-
Clinical and prognostic features of patients with myelodysplastic/ myeloproliferative syndrome categorized as unclassified (MDS/MPD-U) by WHO classification
-
DOI 10.1016/j.leukres.2007.07.004, PII S0145212607002901
-
Cannella L, Breccia M, Latagliata R, Frustaci A, Alimena G. Clinical and prognostic features of patients with myelodysplastic/myeloproliferative syndrome categorized as unclassified (MDS/MPD-U) by WHO classification. Leuk Res 2008; 32: 514-516. (Pubitemid 351295917)
-
(2008)
Leukemia Research
, vol.32
, Issue.3
, pp. 514-516
-
-
Cannella, L.1
Breccia, M.2
Latagliata, R.3
Frustaci, A.4
Alimena, G.5
-
7
-
-
0030897009
-
International scoring system for evaluating prognosis in myelodysplastic syndromes
-
Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079-2088. (Pubitemid 27132124)
-
(1997)
Blood
, vol.89
, Issue.6
, pp. 2079-2088
-
-
Greenberg, P.1
Cox, C.2
LeBeau, M.M.3
Fenaux, P.4
Morel, P.5
Sanz, G.6
Sanz, M.7
Vallespi, T.8
Hamblin, T.9
Oscier, D.10
Ohyashiki, K.11
Toyama, K.12
Aul, C.13
Mufti, G.14
Bennett, J.15
-
8
-
-
63849328927
-
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
-
Cervantes F, Dupriez B, Pereira A, Passamonti F, Reilly JT, Morra E et al. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. Blood 2009; 113: 2895-2901.
-
(2009)
Blood
, vol.113
, pp. 2895-2901
-
-
Cervantes, F.1
Dupriez, B.2
Pereira, A.3
Passamonti, F.4
Reilly, J.T.5
Morra, E.6
-
9
-
-
84866621729
-
Revised international prognostic scoring system for myelodysplastic syndromes
-
Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sole F et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood 2012; 120: 2454-2465.
-
(2012)
Blood
, vol.120
, pp. 2454-2465
-
-
Greenberg, P.L.1
Tuechler, H.2
Schanz, J.3
Sanz, G.4
Garcia-Manero, G.5
Sole, F.6
-
10
-
-
53149113768
-
Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
-
Kantarjian H, O'Brien S, Ravandi F, Cortes J, Shan J, Bennett JM et al. Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System. Cancer 2008; 113: 1351-1361.
-
(2008)
Cancer
, vol.113
, pp. 1351-1361
-
-
Kantarjian, H.1
O'Brien, S.2
Ravandi, F.3
Cortes, J.4
Shan, J.5
Bennett, J.M.6
-
11
-
-
34247646400
-
The incidence and impact of thrombocytopenia in myelodysplasia syndromes
-
DOI 10.1002/cncr.22602
-
Kantarjian H, Giles F, List A, Lyons R, Sekeres MA, Pierce S et al. The incidence and impact of thrombocytopenia in myelodysplastic syndromes. Cancer 2007; 109: 1705-1714. (Pubitemid 46668530)
-
(2007)
Cancer
, vol.109
, Issue.9
, pp. 1705-1714
-
-
Kantarjian, H.1
Giles, F.2
List, A.3
Lyons, R.4
Sekeres, M.A.5
Pierce, S.6
Deuson, R.7
Leveque, J.8
-
12
-
-
28544433130
-
Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)
-
DOI 10.1038/sj.leu.2403963, PII 2403963
-
Germing U, Hildebrandt B, Pfeilstocker M, Nosslinger T, Valent P, Fonatsch C et al. Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS). Leukemia 2005; 19: 2223-2231. (Pubitemid 41741618)
-
(2005)
Leukemia
, vol.19
, Issue.12
, pp. 2223-2231
-
-
Germing, U.1
Hildebrandt, B.2
Pfeilstocker, M.3
Nosslinger, T.4
Valent, P.5
Fonatsch, C.6
Lubbert, M.7
Haase, D.8
Steidl, C.9
Krieger, O.10
Stauder, R.11
Giagounidis, A.A.N.12
Strupp, C.13
Kundgen, A.14
Mueller, T.15
Haas, R.16
Gattermann, N.17
Aul, C.18
-
13
-
-
0025848934
-
Karyotypic patterns in chronic myeloproliferative disorders: Report on 74 cases and review of the literature
-
Mertens F, Johansson B, Heim S, Kristoffersson U, Mitelman F. Karyotypic patterns in chronic myeloproliferative disorders: report on 74 cases and review of the literature. Leukemia 1991; 5: 214-220.
-
(1991)
Leukemia
, vol.5
, pp. 214-220
-
-
Mertens, F.1
Johansson, B.2
Heim, S.3
Kristoffersson, U.4
Mitelman, F.5
-
14
-
-
84890561009
-
A Prognostic Scoring System for Unclassifiable MDS and MDS/MPN
-
Liu Y, Tabarroki A, Visconte V, Hasrouni E, Bupathi M, Hamilton BK et al. A Prognostic Scoring System for Unclassifiable MDS and MDS/MPN. ASH Annual Meeting Abstracts 2012 2012; 120: 1701.
-
(2012)
ASH Annual Meeting Abstracts 2012
, vol.120
, pp. 1701
-
-
Liu, Y.1
Tabarroki, A.2
Visconte, V.3
Hasrouni, E.4
Bupathi, M.5
Hamilton, B.K.6
|